SunTrust analyst Michael Lewis lowered his price target on Healthcare Trust to $30 as part of his broader research note on medical office building REITs to reflect his valuation model changes. The analyst also keeps his Buy rating on the stock and believes that the shift in the healthcare industry toward "outcome-driven care with providers, patients and payors sharing the risk" should favor outpatient locations that include physician offices, home health, outpatient clinics, ambulatory surgery centers, and urgent care facilities. Lewis adds that Healthcare Trust can improve occupancy by over 100bps over the next couple of years, and its valuation may have some room for improvement relative to other healthcare REITs.